Skip to content

Drug interactions

Armodafinil + Larotrectinib

Severity: Minor

Armodafinil and Larotrectinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Larotrectinib is a CYP3A4 substrate and weak inhibitor of CYP3A4, but any rise in armodafinil exposure is unlikely to be clinically important.

What this interaction means in plain words

Armodafinil and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Armodafinil belongs to Central Nervous System; Larotrectinib belongs to Oncology.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition by larotrectinib reducing armodafinil metabolism.

What to do

No routine action needed; watch for increased armodafinil adverse effects such as headache, anxiety or insomnia.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Armodafinil and Larotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Armodafinil with Larotrectinib?

MediHelp rates the interaction as minor. Armodafinil and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Larotrectinib is a CYP3A4 substrate and weak inhibitor of CYP3A4, but any rise in armodafinil exposure is unlikely to be clinically important.

How serious is the interaction between Armodafinil and Larotrectinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine action needed; watch for increased armodafinil adverse effects such as headache, anxiety or insomnia.

What other medicines interact with Armodafinil?

MediHelp also lists interactions of Armodafinil with, for example, Avapritinib, Elacestrant, Elbasvir / grazoprevir. The full list is on the Armodafinil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in